BenjaminPLevyMD

PubMed

• Psoralen: a narrative review of current and future therapeutic uses.
  Daniella D Maydan, Beatrice Schleupner, Alexandra Hunter Aitchison, Andrew D Lerner, Panagis Galiatsatos, Elle Macalpine, Benjamin Levy, Aditya Halthore, William Eward> ;Journal of Cancer Research and Clinical Oncology. 2024 Mar 15
• Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC.
  Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J F...> ;Cancer Research Communications. 2024 Mar 14
• Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application of Emerging Data and New Challenges.
  Angelica D'Aiello, Brendon Stiles, Nitin Ohri, Benjamin Levy, Perry Cohen, Balazs Halmos> ;Clinical Lung Cancer. 2024 Feb 13
• 2 citations
  Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer.
  Murray, J., Sivapalan, L., Hummelink, K., Balan, A., White, J., Niknafs, N., Rhymee, L., Pereira, G., Rao, N., Weksler, B., Bahary, N., Phallen, J., Leal, A., Bartlett...> ;Clinical Cancer Research. 2024 Jan 17
• Clinical and Genomic Characterization of Long-Term Responders Receiving Immune Checkpoint Blockade for Metastatic Non-Small-Cell Lung Cancer.
  Paola Ghanem, Joseph C Murray, Melinda Hsu, Matthew Z Guo, David S Ettinger, Josephine Feliciano, Patrick Forde, Christine L Hann, Vincent K Lam, Benjamin Levy, Valsam...> ;Clinical Lung Cancer. 2024 Mar 1
• 9 citations
  ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results.
  Valsamo Anagnostou, Cheryl Ho, Garth Nicholas, Rosalyn Anne Juergens, Adrian Sacher, Andrea S Fung, Paul Wheatley-Price, Scott A Laurie, Benjamin Levy, Julie R Brahmer...> ;Nature Medicine. 2023 Oct 1
• Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases.
  Paola Ghanem, Joseph C Murray, Kristen A Marrone, Susan C Scott, Josephine L Feliciano, Vincent K Lam, Christine L Hann, David S Ettinger, Benjamin P Levy, Patrick M F...> ;RMD Open. 2023 Oct 1
• 4 citations
  TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC.
  Benjamin P Levy, Enriqueta Felip, Martin Reck, James Ch Yang, Federico Cappuzzo, Yasuto Yoneshima, Caicun Zhou, Siddhartha Rawat, Jingdong Xie, Priyanka Basak, Lu Xu, ...> ;Future Oncology. 2023 Jul 1
• Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Har...
  J Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, Benjamin P Levy, Hossein Borghaei, Bruna Pellini, Michael R Costello, Jonathan E Dowell, Gene Finley, Chao H Huang,...> ;Clinical Lung Cancer. 2023 Nov 1
• 3 citations
  Antibody-Drug Conjugates for Lung Cancer: Payloads and Progress.
  Samuel Rosner, Augusto Valdivia, Hui Jing Hoe, Joseph C Murray, Benjamin Levy, Enriqueta Felip, Benjamin J Solomon> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 May 1
• 35 citations
  Persistent mutation burden drives sustained anti-tumor immune responses.
  Noushin Niknafs, Archana Balan, Christopher Cherry, Karlijn Hummelink, Kim Monkhorst, Xiaoshan M Shao, Zineb Belcaid, Kristen A Marrone, Joseph Murray, Kellie N Smith,...> ;Nature Medicine. 2023 Feb 1
• 19 citations
  Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy.
  Lavanya Sivapalan, Joseph C Murray, Jenna VanLiere Canzoniero, Blair Landon, Jennifer Jackson, Susan Scott, Vincent Lam, Benjamin P Levy, Mark Sausen, Valsamo Anagnostou> ;Journal for Immunotherapy of Cancer. 2023 Jan 1
• 7 citations
  Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.
  Melinda L Hsu, Joseph C Murray, Kevin J Psoter, Jiajia Zhang, Durrant Barasa, Julie R Brahmer, David S Ettinger, Patrick M Forde, Christine L Hann, Vincent K Lam, Benj...> ;The Oncologist. 2022 Nov 3
• Relapsed small-cell lung cancer: a disease of continued unmet need.
  Samuel Rosner, Benjamin Levy> ;The Lancet. Respiratory Medicine. 2023 Jan 1
• 3 citations
  Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer.
  Matthew Z Guo, Joseph C Murray, Paola Ghanem, K Ranh Voong, Russell K Hales, David Ettinger, Vincent K Lam, Christine L Hann, Patrick M Forde, Julie R Brahmer, Benjami...> ;Clinical Lung Cancer. 2022 Nov 1
• 32 citations
  Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy.
  Michael Hwang, Jenna Vanliere Canzoniero, Samuel Rosner, Guangfan Zhang, James R White, Zineb Belcaid, Christopher Cherry, Archana Balan, Gavin Pereira, Alexandria Cur...> ;Journal for Immunotherapy of Cancer. 2022 Jun 1
• 3 citations
  Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-L...
  Benjamin Levy, Fabrice Barlesi, Luis Paz-Ares, Jaafar Bennouna, Mustafa Erman, Enriqueta Felip, Dolores Isla, Hye Ryun Kim, Sang-We Kim, Jeannick Madelaine, Olivier Mo...> ;Lung Cancer. 2022 Apr 1
• 4 citations
  Sex-specific differences in immunogenomic features of response to immune checkpoint blockade.
  Susan C Scott, Xiaoshan M Shao, Noushin Niknafs, Archana Balan, Gavin Pereira, Kristen A Marrone, Vincent K Lam, Joseph C Murray, Josephine L Feliciano, Benjamin P Lev...> ;Frontiers in Oncology. 2022 Jan 1
• 4 citations
  Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC.
  Joshua E. Reuss, Emily P. Brigham, Kevin J. Psoter, Khinh Ranh Voong, Bairavi Shankar, David S. Ettinger, Kristen A. Marrone, Christine L. Hann, Benjamin Levy, Josephi...> ;JTO Clinical and Research Reports. 2021 Oct 1
• 4 citations
  Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
  Pavan P. Shah, Jennifer L. Franke, Christopher M. Jackson, Siddhartha Srivastava, John Choi, Patrick M. Forde, Julie R. Brahmer, David S. Ettinger, Josephine Feliciano...> ;Journal of Neurosurgery. 2021 Jun 4
• 2 citations
  Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study
  Edward B. Garon, Katherine B. Winfree, Cliff Molife, Zhanglin Lin Cui, Edurne Arriola, Benjamin Levy, Tarek Mekhail, Maurice Pérol> ;Supportive Care in Cancer. 2021 Jan 1
• 316 citations
  Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;The New England Journal of Medicine. 2020 Aug 26
• 8 citations
  Consolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction Nomogram.
  Cole Friedes, Nicholas Mai, Sarah Z. Hazell, Wei Fu, Peijin Han, M.R. Bowers, Benjamin Levy, Patrick M. Forde, R. Voong, Russell K. Hales> ;Clinical Lung Cancer. 2020 May 23
• 72 citations
  Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.
  Bryan J. Schneider, Nofisat Ismaila, Joachim G.J.V. Aerts, Caroline Chiles, Megan E. Daly, Frank C. Detterbeck, Jason W.D. Hearn, Sharyn I. Katz, Natasha B. Leighl, Be...> ;Journal of Clinical Oncology. 2020 Mar 1
• 114 citations
  Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
  Valsamo Anagnostou, Noushin Niknafs, Kristen A. Marrone, Daniel C. Bruhm, James R. White, Jarushka Naidoo, Karlijn Hummelink, Kim Monkhorst, Ferry Lalezari, Mara Lanis...> ;Nature Cancer. 2020 Jan 13
• Join now to see all